Glenmark gets approval for colesevelam hydrochloride tablets
MUMBAI, India — Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food and Drug Administration (FDA) for colesevelam hydrochloride tablets, 625 mg, the generic version of Welchol Tablets, 625 mg, of Daiichi Sankyo Inc. The company has already commenced supplies of the product to the U.S. market. According to
